ArticleCancers2021

BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute Leukemia.

Katja Seipel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.